# Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

> **NCT04271501** · NA · TERMINATED · sponsor: **Avita Medical** · enrollment: 5 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **PROCEDURE:** Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB)
- **DEVICE:** RECELL 1:5 and Ultraviolet Lamp (UVB)
- **DEVICE:** RECELL 1:10 and Ultraviolet Lamp (UVB)
- **DEVICE:** RECELL 1:20 and Ultraviolet Lamp (UVB)

## Key facts

- **NCT ID:** NCT04271501
- **Lead sponsor:** Avita Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-25
- **Primary completion:** 2021-08-24
- **Final completion:** 2021-08-24
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Suspended and Terminated to focus on CTP009 (NCT04547998) Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04271501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04271501, "Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04271501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*